What are the peptide drugs for treating diabetes on the global market?
Peptide refers to a compound with less than 100 amino acids linked twice through a peptide bond, and its relative molecular mass is less than 10,000. Polypeptide drugs are used in the treatment of tumors, diabetes, cardiovascular diseases, osteoporosis, gastrointestinal diseases, and central nervous system. , System diseases, immune diseases, antiviral, antibacterial, etc. have significant effects. There are more than 80 GMP peptide drugs approved for marketing globally, including 17 anti-tumor drugs, 7 diabetes treatment drugs, 16 infection and immunotherapy drugs, and 9 vascular and urinary system drugs. Here are the peptides for the treatment of diabetes:
Peptide drug | Trade name | Indications | Route of administration | FDA listing time |
Exenatide | Byetta/Bydureon | Stage 2 diabetes | subcutaneous injection | 2014 |
Albiglutide | Tanzeum | Stage 2 diabetes | subcutaneous injection | 2014 |
Dulaglucotide | Trulicity | Stage 2 diabetes | subcutaneous injection | 2014 |
Victoza | Stage 2 diabetes and obesity | subcutaneous injection | 2014 | |
Lixilai | Lyxumia | subcutaneous injection | / | |
Pramlintide | Symlin | Phase 1,2 of diabetes | subcutaneous injection | 2005 |
Glucagon | Glucagon | hypoglycemia | subcutaneous and intramuscular injection | 1998 |
Omizzur Peptide Catalogue
Peptide reagents in stock Download
Customer Service Center
Phone: 400-777-8404
Order: [email protected]
Copyright © 2020 Omizzur Inc | Terms & Conditions | Privacy Notice | Sitemap